CLINICAL TRIAL / NCT06431373
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
- Interventional
- Active
- NCT06431373
Contact Information
- Quadis Evans
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).